Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. (Q54072767)

24 May 2018

title

Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. (English)

1 reference

24 May 2018

main subject

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

O'Brien CB

1

1 reference

24 May 2018

Senior JR

2

1 reference

24 May 2018

Arora-Mirchandani R

3

1 reference

24 May 2018

Batta AK

4

1 reference

24 May 2018

Salen G

5

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 November 1991

1 reference

24 May 2018

published in

Hepatology

1 reference

24 May 2018

volume

14

1 reference

24 May 2018

issue

5

1 reference

24 May 2018

page(s)

838-847

1 reference

24 May 2018

Percutaneous transhepatic balloon dilatation of benign biliary strictures

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

Dissolution of Cholesterol Gallstones by Chenodeoxycholic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

Impact of age on weight goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Current concepts. Primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Outcome of primary sclerosing cholangitis. Analysis of long-term observation of 38 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Association of primary sclerosing cholangitis and celiac disease: fact or fancy?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Recent advances in the management of primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Effect of long-term tetracycline therapy, steroid therapy and colectomy in pericholangitis associated with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Sclerosing cholangitis: palliation with percutaneous cholangioplasty

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Endoscopic treatment of biliary duct strictures in sclerosing cholangitis: follow-up assessment of a new therapeutic approach

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Biliary lavage with corticosteroids in primary sclerosing cholangitis. A clinical, cholangiographic and bacteriological study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

The role of nontransplant procedures for sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Resection of Hepatic Duct Bifurcation and Transhepatic Stenting for Sclerosing Cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Primary sclerosing cholangitis: biliary drainage and duct dilatation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Primary sclerosing cholangitis and low-dose oral pulse methotrexate therapy. Clinical and histologic response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Orthotopic liver transplantation for primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Liver transplantation: an overview

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Liver transplantation (1).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Dissolution of cholesterol gallstones by ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Analysis of response to ursodeoxycholic acid for gallstone dissolution

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Gallbladder emptying response to sham feeding in humans

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Effect of estradiol upon serum enzymes in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Cortisone in ulcerative colitis; final report on a therapeutic trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Clinical activity assessment in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Effect of Oral Chenodeoxycholic Acid on Bile Acid Kinetics and Biliary Lipid Composition in Women with Cholelithiasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

No decrease in duodenal ulcer surgery after cimetidine in Hong Kong.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties--studies on isolated hepatocytes and lipid membrane vesicles

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Ileal excretion of bile acids: Comparison with biliary bile composition and effect of ursodeoxycholic acid treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Ursodeoxycholic acid for primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840140516

7 January 2021

Identifiers

DOI

10.1002/HEP.1840140516

1 reference

24 May 2018

1 reference

24 May 2018